|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Tff Pharmaceuticals, Inc. (TFFP) |
|
|
$0.32 0.00 (0.00%) as of 4:30 Mon 12/18
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
18,450,000 |
| Market
Cap: |
5.90(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.22 - $0.7724 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TFF Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing technology platform. Co. has two product candidates under development, TFF Voriconazole Inhalation Powder and TFF Tacrolimus Inhalation Powder. Co. is engaged in the joint development of an inhaled SARS-CoV2 Monoclonal Antibody in collaboration with Augmenta Bioworks, Inc. and a dry powder formulation of niclosamide in collaboration agreement with UNION therapeutics A/S. Co. is also engaged in the analysis and testing of dry powder formulations of several drugs and vaccines through topical, ocular and nasal applications.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
820,000 |
1,243,360 |
| Total Buy Value |
$0 |
$0 |
$205,000 |
$1,157,770 |
| Total People Bought |
0 |
0 |
6 |
8 |
| Total Buy Transactions |
0 |
0 |
6 |
21 |
| Total Shares Sold |
0 |
0 |
216,000 |
256,255 |
| Total Sell Value |
$0 |
$0 |
$94,433 |
$267,127 |
| Total People Sold |
0 |
0 |
1 |
2 |
| Total Sell Transactions |
0 |
0 |
2 |
3 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Carlson Clint Duane |
10% Owner |
– – • |
2023-08-16 |
4 |
S |
$0.39 |
$392 |
I/I |
(1,000) |
5,064,000 |
|
14% |
|
| Carlson Clint Duane |
10% Owner |
– – • |
2023-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,280,000 |
|
-22% |
|
| Carlson Clint Duane |
10% Owner |
– – • |
2023-08-15 |
4 |
S |
$0.44 |
$94,041 |
I/I |
(215,000) |
5,065,000 |
|
22% |
|
| Mills Robert S |
Director |
– • – |
2023-08-15 |
4 |
B |
$0.25 |
$10,000 |
D/D |
40,000 |
55,980 |
2.39 |
-22% |
|
| Coleman Kirk Allen |
Chief Financial Officer |
• – – |
2023-08-15 |
4 |
B |
$0.25 |
$5,000 |
D/D |
20,000 |
35,675 |
2.74 |
-22% |
|
| Rocamboli Stephen |
Director |
– • – |
2023-08-15 |
4 |
B |
$0.25 |
$5,000 |
D/D |
20,000 |
36,000 |
2.39 |
-22% |
|
| Mikhak Zamaneh |
Chief Medical Officer |
• – – |
2023-08-15 |
4 |
B |
$0.25 |
$30,000 |
D/D |
120,000 |
135,000 |
2.74 |
-22% |
|
| Roberts Brandi |
Director |
– • – |
2023-08-15 |
4 |
B |
$0.25 |
$5,000 |
D/D |
20,000 |
20,000 |
2.39 |
-22% |
|
| Weisman Harlan F |
President and CEO |
• • – |
2023-08-15 |
4 |
B |
$0.25 |
$150,000 |
D/D |
600,000 |
814,615 |
2.81 |
-22% |
|
| Weisman Harlan F |
President and CEO |
• • – |
2023-03-10 |
4 |
B |
$0.88 |
$131,835 |
D/D |
150,000 |
214,615 |
2.81 |
-49% |
|
| Coleman Kirk Allen |
Chief Financial Officer |
• – – |
2023-03-10 |
4 |
B |
$0.79 |
$9,457 |
D/D |
12,000 |
15,675 |
2.74 |
-49% |
|
| Mikhak Zamaneh |
Chief Medical Officer |
• – – |
2023-03-10 |
4 |
B |
$0.82 |
$12,300 |
D/D |
15,000 |
15,000 |
2.74 |
-49% |
|
| Rocamboli Stephen |
Director |
– • – |
2023-03-10 |
4 |
B |
$0.80 |
$10,433 |
D/D |
13,000 |
16,000 |
2.39 |
-49% |
|
| Weisman Harlan F |
President and CEO |
• • – |
2022-12-15 |
4 |
B |
$1.06 |
$53,000 |
D/D |
50,000 |
64,615 |
2.81 |
-45% |
|
| Fletcher Aaron G.l. |
Director |
– • – |
2022-11-22 |
4 |
B |
$1.15 |
$49,991 |
D/D |
43,470 |
143,470 |
2.39 |
-56% |
|
| Thurman Randy H |
Director |
– • – |
2022-09-29 |
4 |
S |
$4.29 |
$172,694 |
D/D |
(40,255) |
0 |
|
79% |
|
| Thurman Randy H |
Director |
– • – |
2022-09-29 |
4 |
OE |
$2.50 |
$100,638 |
D/D |
40,255 |
40,255 |
|
- |
|
| Weisman Harlan F |
Director |
– • – |
2022-05-20 |
4 |
B |
$5.50 |
$25,383 |
D/D |
4,615 |
14,615 |
2.39 |
-26% |
|
| Weisman Harlan F |
Director |
– • – |
2022-05-18 |
4 |
B |
$5.12 |
$12,800 |
D/D |
2,500 |
10,000 |
2.39 |
-7% |
|
| Coleman Kirk Allen |
Chief Financial Officer |
• – – |
2022-05-17 |
4 |
B |
$4.83 |
$2,053 |
D/D |
425 |
3,675 |
2.66 |
-12% |
|
| Fletcher Aaron G.l. |
Director |
– • – |
2022-05-17 |
4 |
B |
$5.08 |
$124,968 |
I/I |
24,600 |
109,600 |
2.1 |
-12% |
|
| Mattes Glenn R. |
President and CEO |
• • – |
2022-05-16 |
4 |
B |
$4.78 |
$76,480 |
D/D |
16,000 |
36,000 |
2.81 |
-6% |
|
| Rocamboli Stephen |
Director |
– • – |
2022-05-16 |
4 |
B |
$4.54 |
$13,620 |
D/D |
3,000 |
18,722 |
2.39 |
-6% |
|
| Weisman Harlan F |
Director |
– • – |
2022-05-16 |
4 |
B |
$4.74 |
$11,850 |
D/D |
2,500 |
7,500 |
2.39 |
-6% |
|
| Coleman Kirk Allen |
Chief Financial Officer |
• – – |
2022-05-16 |
4 |
B |
$4.40 |
$5,500 |
D/D |
1,250 |
3,250 |
2.74 |
-6% |
|
93 Records found
|
|
Page 1 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
